PACTR202404524950258尚未招募4 期
A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Long-acting.
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 710
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 Year(s) 至 5 Year(s)（—）
- 性别
- All
入选标准
- •Participants (or their legally acceptable representative) must sign an informed consent form indicating that they understand the purpose of, and procedures required for the study and are willing to participate in the study
- •Participants living with HIV-1 infection who were treated with CAB LA + RPV LA in any of the following parent studies: TMC278LAHTX3002 (CARES), TMC278LAHTX3005 (IMPALA), IMPAACT 2017 (MOCHA), IMPAACT 2036 (CRAYON), IMPAACT 2040 (CREATE), and completed the protocol-defined treatment period
- •- Has benefited clinically from treatment with CAB LA + RPV LA in the opinion of the investigator
- •- Must be able and willing to comply with the rollover protocol requirements
- •- Participant’s general medical condition, in the opinion of the investigator, does not interfere with participation in this study
排除标准
- •Participants using disallowed concomitant treatment
- •Participants who were withdrawn from the previous parent study with CAB LA + RPV LA that they were participating in prior to this rollover study, based on any of the mandatory withdrawal criteria
研究者
相似试验
进行中（未招募）
1 期
Cabotegravir + Rilpivirine Long-Acting Injection Rollover StudyHuman Immunodeficiency Virus 1MedDRA version: 20.1Level: LLTClassification code 10020443Term: Human immunodeficiency virus syndromeSystem Organ Class: 10021881 - Infections and infestationsEUCTR2023-001064-26-Outside-EU/EEAJanssen-Cilag International NV
进行中（未招募）
1 期
A prospective, randomised, phase IV, open label clinical trial to study the therapeutic use of buprenorphine 20 mg (BuTrans 20µg/h) matrix transdermal patch in the management of post tonsillectomy pain in adults - PATCH TrialEUCTR2007-006117-16-GBBetsi Cadwaladr University Health Board300
进行中（未招募）
1 期
DREAM studyEUCTR2016-004646-29-ESFundación SEIMC-GESIDA64
进行中（未招募）
1 期
A study of subjects with Psoriatic Arthritis to investigate the effectiveness of adalimumab introduction compared with methotrexate dose escalatioMedDRA version: 19.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 100000004859Psoriatic ArthritisEUCTR2016-000191-21-CZAbbVie Deutschland GmbH & Co. KG240
进行中（未招募）
1 期
A study of subjects with Psoriatic Arthritis to investigate the effectiveness of adalimumab introduction compared with methotrexate dose escalatioMedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 100000004859Psoriatic ArthritisEUCTR2016-000191-21-ITABBVIE DEUTSCHLAND GMBH & CO. KG245